The market for whole genome and exome sequencing is set to grow significantly, driven by decreasing sequencing costs and a ...
DUBLIN--(BUSINESS WIRE)--The "Whole Exome Sequencing Market - A Global and Regional Analysis: Focus on Product, Workflow, Application, End User, and Country - Analysis and Forecast, 2024-2034" report ...
SAN DIEGO--(BUSINESS WIRE)--Element Biosciences, Inc., a developer of pioneering technologies to empower science, today introduced Trinity™ - an innovative solution that simplifies target capture ...
In today’s rapidly evolving landscape of next-generation sequencing (NGS), researchers face mounting pressure to deliver high-quality data from increasingly diverse and challenging sample types. From ...
Genetic mutations in human DNA can prevent proteins that perform important functions in the body from being formed correctly. This can lead to serious disorders that cause disease or even disability.
In genome sequencing, everything needs to be just right. It should be just right in terms of data quality, turnaround time, cost, and equipment ease of use. In some cases, those criteria are crucial.
The Illumina NovaSeq X adds to Agilus Diagnostics’ molecular testing portfolio through high-throughput sequencing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results